MOXIFLOXACINO 7 TAB 400 MG BACILOS LACTICOS PRINCIPIO ACTIVO: OXICONAZOL

Description

PRINCIPIO ACTIVO: OXICONAZOL

JAKAVI® 5 mg es un medicamento de uso oral que contiene Ruxolitinib

057M2019 SSA

Proteger de la luz y humedad

PRINCIPIO ACTIVO: SULFAMETOXAZOL

MOXIFLOXACINO 7 TAB 400 MG BACILOS LACTICOS PRINCIPIO ACTIVO: OXICONAZOLMOXIFLOXACINO 400. 00 MG

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy